[Inhibition of arginine-stimulated pancreatic glucagon secretion with biosynthetic human insulin and swine insulin in healthy subjects and diabetics]. 1983

S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos

UI MeSH Term Description Entries
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
September 1976, The Journal of clinical investigation,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
December 1982, The American journal of physiology,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
November 1974, Diabetes,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
January 1975, Revista de gastroenterologia de Mexico,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
January 1976, Metabolism: clinical and experimental,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
May 1974, Metabolism: clinical and experimental,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
January 1979, Diabetes,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
February 1985, Experimental and clinical endocrinology,
S Raptis, and D Hadjidakis, and F Enzmann, and A Raptis, and E Diamantopoulos
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!